PRINCETON, NJ -- (MARKET WIRE) -- January 16, 2007 -- New Life Scientific, Inc. (OTCBB: NWLS), a company which specializes in the development of new biotechnology products and pharmaceuticals, announced today that it has entered into an exclusive license agreement for two platform technologies (patent pending) that will allow formulation of topical drugs for various applications.
